These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
708 related articles for article (PubMed ID: 19014387)
1. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells. Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246 [TBL] [Abstract][Full Text] [Related]
3. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. Ono K; Hasegawa K; Naiki H; Yamada M J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335 [TBL] [Abstract][Full Text] [Related]
4. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506 [TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression. Wang PY; Chen JJ; Su HM J Nutr Biochem; 2010 Apr; 21(4):345-50. PubMed ID: 19423322 [TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease. Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184 [TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidity. Hashimoto M; Hossain S; Shimada T; Shido O Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):934-9. PubMed ID: 17002670 [TBL] [Abstract][Full Text] [Related]
8. Effects of docosahexaenoic acid on in vitro amyloid beta peptide 25-35 fibrillation. Hashimoto M; Shahdat HM; Katakura M; Tanabe Y; Gamoh S; Miwa K; Shimada T; Shido O Biochim Biophys Acta; 2009 Apr; 1791(4):289-96. PubMed ID: 19416653 [TBL] [Abstract][Full Text] [Related]
9. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Hooijmans CR; Van der Zee CE; Dederen PJ; Brouwer KM; Reijmer YD; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Kiliaan AJ Neurobiol Dis; 2009 Mar; 33(3):482-98. PubMed ID: 19130883 [TBL] [Abstract][Full Text] [Related]
10. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089 [TBL] [Abstract][Full Text] [Related]